
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Bacillus licheniformis is a spore-forming soil-based probiotic that supports gut health by colonizing the intestinal tract and producing antimicrobial peptides. This probiotic modulates immune responses through interaction with gut-associated lymphoid tissue, contributing to reduced inflammation.

Reported Benefits (Provisional)
Origin & History

Bacillus licheniformis is a soil-based probiotic strain found in soil and marine environments. It is produced through fermentation and is known for its enzyme production capabilities.
Research Narrative (Provisional)
Emerging studies suggest its role in supporting digestive health and immune function. In vitro studies highlight its enzyme production capabilities.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Produces enzymes that aid in digestion and nutrient absorption. - Contains spores that ensure survival through the digestive tract. - Supports the production of beneficial short-chain fatty acids.
Reported Mechanism (Provisional)
Bacillus licheniformis exerts its probiotic effects primarily through the production of antimicrobial compounds like bacitracin and bacteriocins, which inhibit the growth of pathogenic bacteria. It adheres to the intestinal epithelium, forming a protective biofilm and competing with pathogens for nutrient resources and adhesion sites. Furthermore, this probiotic stimulates the release of immunomodulatory cytokines, such as IL-10, by interacting with Toll-like receptors on intestinal immune cells, thereby modulating host immune responses and reducing inflammation.
Clinical Narrative (Provisional)
Preliminary human trials and in vitro studies suggest Bacillus licheniformis significantly supports gut microbiome balance. A randomized, placebo-controlled trial involving 80 adults demonstrated a 25% increase in beneficial Bifidobacterium species and a 30% reduction in C-reactive protein (CRP) levels after 8 weeks of supplementation. While promising, larger-scale, long-term clinical trials are needed to fully establish its efficacy across diverse populations and for specific health conditions. Current evidence indicates a strong potential for modulating gut health and systemic inflammation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







